S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   266.87 (-1.28%)
AAPL   106.84 (-3.17%)
MSFT   200.39 (-1.24%)
FB   252.53 (-0.90%)
GOOGL   1,451.09 (-2.42%)
AMZN   2,954.91 (-1.79%)
NVDA   487.57 (-2.20%)
TSLA   442.15 (+4.42%)
BABA   272.41 (-1.20%)
CGC   16.36 (-0.24%)
GE   6.88 (-2.41%)
MU   50.74 (-0.47%)
AMD   74.93 (-2.12%)
T   28.93 (-0.48%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   469.96 (-0.05%)
DIS   128.63 (-1.22%)
BAC   25.21 (-0.55%)
BA   161.14 (-3.81%)
S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   266.87 (-1.28%)
AAPL   106.84 (-3.17%)
MSFT   200.39 (-1.24%)
FB   252.53 (-0.90%)
GOOGL   1,451.09 (-2.42%)
AMZN   2,954.91 (-1.79%)
NVDA   487.57 (-2.20%)
TSLA   442.15 (+4.42%)
BABA   272.41 (-1.20%)
CGC   16.36 (-0.24%)
GE   6.88 (-2.41%)
MU   50.74 (-0.47%)
AMD   74.93 (-2.12%)
T   28.93 (-0.48%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   469.96 (-0.05%)
DIS   128.63 (-1.22%)
BAC   25.21 (-0.55%)
BA   161.14 (-3.81%)
S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   266.87 (-1.28%)
AAPL   106.84 (-3.17%)
MSFT   200.39 (-1.24%)
FB   252.53 (-0.90%)
GOOGL   1,451.09 (-2.42%)
AMZN   2,954.91 (-1.79%)
NVDA   487.57 (-2.20%)
TSLA   442.15 (+4.42%)
BABA   272.41 (-1.20%)
CGC   16.36 (-0.24%)
GE   6.88 (-2.41%)
MU   50.74 (-0.47%)
AMD   74.93 (-2.12%)
T   28.93 (-0.48%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   469.96 (-0.05%)
DIS   128.63 (-1.22%)
BAC   25.21 (-0.55%)
BA   161.14 (-3.81%)
S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   266.87 (-1.28%)
AAPL   106.84 (-3.17%)
MSFT   200.39 (-1.24%)
FB   252.53 (-0.90%)
GOOGL   1,451.09 (-2.42%)
AMZN   2,954.91 (-1.79%)
NVDA   487.57 (-2.20%)
TSLA   442.15 (+4.42%)
BABA   272.41 (-1.20%)
CGC   16.36 (-0.24%)
GE   6.88 (-2.41%)
MU   50.74 (-0.47%)
AMD   74.93 (-2.12%)
T   28.93 (-0.48%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   469.96 (-0.05%)
DIS   128.63 (-1.22%)
BAC   25.21 (-0.55%)
BA   161.14 (-3.81%)
Log in
NASDAQ:CLXT

Calyxt Stock Forecast, Price & News

$6.38
+0.16 (+2.57 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$6.04
Now: $6.38
$6.39
50-Day Range
$4.41
MA: $5.70
$7.65
52-Week Range
$2.40
Now: $6.38
$8.41
Volume124,449 shs
Average Volume109,527 shs
Market Capitalization$211.71 million
P/E RatioN/A
Dividend YieldN/A
Beta2.35
Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. operates as a subsidiary of Cellectis S.A.
Read More
Calyxt logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.1Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.04 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
Current SymbolNASDAQ:CLXT
CUSIPN/A
Phone651-683-2807

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.30 million
Book Value$1.90 per share

Profitability

Net Income$-39,610,000.00
Net Margins-392.49%

Miscellaneous

Employees50
Market Cap$211.71 million
Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
$6.38
+0.16 (+2.57 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Calyxt (NASDAQ:CLXT) Frequently Asked Questions

How has Calyxt's stock been impacted by Coronavirus?

Calyxt's stock was trading at $3.34 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CLXT stock has increased by 91.0% and is now trading at $6.38.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Calyxt?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Calyxt
.

When is Calyxt's next earnings date?

Calyxt is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Calyxt
.

How were Calyxt's earnings last quarter?

Calyxt Inc (NASDAQ:CLXT) announced its quarterly earnings results on Wednesday, August, 5th. The company reported ($0.33) EPS for the quarter, beating analysts' consensus estimates of ($0.36) by $0.03. The business earned $2.31 million during the quarter. Calyxt had a negative return on equity of 77.67% and a negative net margin of 392.49%.
View Calyxt's earnings history
.

What price target have analysts set for CLXT?

6 brokerages have issued 12-month target prices for Calyxt's shares. Their forecasts range from $4.00 to $10.00. On average, they anticipate Calyxt's share price to reach $7.20 in the next year. This suggests a possible upside of 12.9% from the stock's current price.
View analysts' price targets for Calyxt
.

Who are some of Calyxt's key competitors?

What other stocks do shareholders of Calyxt own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calyxt investors own include Cellectis (CLLS), Molecular Templates (MTEM), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Cypress Semiconductor (CY), Eaton (ETN), Square (SQ), AT&T (T), AbbVie (ABBV) and Activision Blizzard (ATVI).

Who are Calyxt's key executives?

Calyxt's management team includes the following people:
  • Mr. James A. Blome, Chief Exec. Officer (Age 56)
  • Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 56)
  • Mr. Manoj Sahoo, Chief Commercial Officer (Age 44)
  • Mr. William F. Koschak, Chief Financial Officer (Age 50)
  • Mr. Eric Dutang, Principal Accounting Officer (Age 45)

When did Calyxt IPO?

(CLXT) raised $101 million in an initial public offering on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities served as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

Who are Calyxt's major shareholders?

Calyxt's stock is owned by a variety of institutional and retail investors. Top institutional investors include FMR LLC (11.62%), Sumitomo Mitsui Trust Holdings Inc. (1.41%), Essex Investment Management Co. LLC (0.20%), HighTower Advisors LLC (0.14%), Nuveen Asset Management LLC (0.10%) and Charles Schwab Investment Management Inc. (0.07%). Company insiders that own Calyxt stock include Andre Choulika, Anna Ewa Kozicz-Stankiewicz, Daniel F Voytas, James Blome, Manoj Sahoo, Philippe Dumont, Travis Frey and Yves J Ribeill.
View institutional ownership trends for Calyxt
.

Which major investors are selling Calyxt stock?

CLXT stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Sumitomo Mitsui Trust Holdings Inc., Nuveen Asset Management LLC, Charles Schwab Investment Management Inc., HighTower Advisors LLC, Essex Investment Management Co. LLC, and Goldman Sachs Group Inc.. Company insiders that have sold Calyxt company stock in the last year include Andre Choulika, Anna Ewa Kozicz-Stankiewicz, James Blome, Philippe Dumont, and Yves J Ribeill.
View insider buying and selling activity for Calyxt
.

Which major investors are buying Calyxt stock?

CLXT stock was bought by a variety of institutional investors in the last quarter, including Bank of America Corp DE. Company insiders that have bought Calyxt stock in the last two years include Philippe Dumont, and Travis Frey.
View insider buying and selling activity for Calyxt
.

How do I buy shares of Calyxt?

Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $6.38.

How big of a company is Calyxt?

Calyxt has a market capitalization of $211.71 million and generates $7.30 million in revenue each year. The company earns $-39,610,000.00 in net income (profit) each year or ($1.21) on an earnings per share basis. Calyxt employs 50 workers across the globe.

What is Calyxt's official website?

The official website for Calyxt is www.calyxt.com.

How can I contact Calyxt?

Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at 651-683-2807 or via email at [email protected]

This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.